Cyclosporine is used to prevent organ rejection in people who have received a liver, kidney, or heart transplant.If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Olysio is Indicated for treatment of chronic hepatitis C (CHC); efficacy has been established in combination with peginterferon alfa and ribavirin in patients with HCV genotype 1 infection with compensated liver disease (including cirrhosis).
In all patients, simeprevir should be initiated in combination with peginterferon alfa and ribavirin and should be administered for 12 weeks
All treatment-naïve and prior relapser patients, including those with cirrhosis, should receive an additional 12 weeks of peginterferon alfa and ribavirin after completing 12 weeks of treatment with simeprevir, peginterferon alfa, and ribavirin (total treatment duration of 24 weeks)
All prior nonresponders (including partial and null-responders and those with cirrhosis), should receive an additional 36 weeks of peginterferon alfa and ribavirin after completing 12 weeks of simeprevir, peginterferon alfa, and ribavirin (total treatment duration of 48 weeks)
Discontinue if inadequate virologic response:
Monitor HCV RNA levels to determine the virologic response
It is unlikely that patients with the inadequate on-treatment virologic response will achieve a sustained virologic response (SVR), therefore discontinuation of treatment is recommended in these patients
HCV-RNA levels at week 4 ≥25 IU/mL: Discontinue simeprevir, peginterferon alfa, and ribavirin
HCV-RNA levels at week 4 ≥25 IU/mL: Discontinue simeprevir, peginterferon alfa, and ribavirinHCV-RNA levels at week 12 ≥25 IU/mL: Discontinue peginterferon alfa and ribavirin (treatment with simeprevir completed at week 12), and ribavirin
HCV-RNA levels at week 24 ≥25 IU/mL: Discontinue peginterferon alfa and ribavirin
OLYSIO is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
OLYSIO efficacy has been established in combination with peginterferon alfa and ribavirin in HCV genotype 1 infected subjects with compensated liver disease (including cirrhosis).
OLYSIO must not be used as monotherapy.
Screening patients with HCV genotype 1a infection for the presence of virus with the NS3 Q80K polymorphism at baseline is strongly recommended. Alternative therapy should be considered for patients infected with HCV genotype 1a containing the Q80K polymorphism.
Medicine Name: Panimun Bioral
Generic Name: Cyclosporine
Available as (Form & Strength): Capsules: 25mg, 50mg, 100mg
Company Name: Panacea Biotec.
Please contact +91 9818274099 for Olysio Simeprevir Capsules 150 mg 400mg price in India
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
OLYSIO (simeprevir) 150 mg capsules are white, marked with â€œTMC435 150â€ in black ink. The capsules are packaged into a bottle containing 28 capsules (NDC 59676â€‘225â€‘28) or a bottle of 7 capsules (emergency supply; NDC 59676â€‘225â€‘07).
Store OLYSIO capsules in the original bottle in order to protect from light. Store OLYSIO capsules at room temperature below 30Â°C (86Â°F).
OLYSIO should not be taken alone.
It is not known if OLYSIO is safe and effective in children under 18 years of age.
DAKLINZA (daclatasvir) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand DAKLINZA (daclatasvir) tablets on prescription and Import License in Patient’s Name only.
For foreign countries patients, DAKLINZA (daclatasvir) tablets can be made available in Send your inquiry to find DAKLINZA (daclatasvir) tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For DAKLINZA (daclatasvir) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details